Adriana Zupa Fernandez (She/Her)
About Adriana Zupa Fernandez (She/Her)
Adriana Zupa Fernandez is the People Business Resource Group Global Lead at Bristol-Myers Squibb, with a diverse background in research and leadership roles within the pharmaceutical industry.
Title
Adriana Zupa Fernandez holds the title of People Business Resource Group Global Lead, currently working at Bristol-Myers Squibb in the United States.
Past Experience at Bristol-Myers Squibb
Adriana Zupa Fernandez has had a long and progressive career at Bristol-Myers Squibb. She began as Associate Research Scientist II in Immunology from 2007 to 2010, transitioned to Research Scientist I in Immunology (2010-2015), then became Research Scientist II in Immunology (2015-2017). From 2017 to 2019, she served as Clinical Site Manager in Princeton, New Jersey.
Previous Roles in Pharmaceutical and Research Institutions
Prior to her extensive tenure at Bristol-Myers Squibb, Adriana held notable roles at several institutions. She was a Research Associate focusing on the Central Nervous System at Johnson & Johnson Pharmaceutical Research and Development from 2005 to 2007. Before that, she worked at the University of Pennsylvania School of Medicine as a Research Specialist in Neuro-Oncology from 2003 to 2005. Her earlier career included research assistant roles in Drexel Co-op programs at GSK (2001-2002) and AstraZeneca (1999-2001).
Education
Adriana Zupa Fernandez completed her Executive MBA at Drexel University's LeBow College of Business between 2019 and 2021. She holds a Graduate Certification in Clinical Research from Villanova University, obtained in 2007, and earned a B.S. in Biology from Drexel University, where she studied Biology, Chemistry, and Medicine from 1998 to 2003.
Achievements and Contributions
In her role at Bristol-Myers Squibb, Adriana significantly impacted organizational growth and diversity. She transformed a small team into a high-functioning leadership team and integrated the BMS and Celgene cultures post-acquisition. She also played a role in discovering clinical candidates TYK2 and BTK for autoimmune diseases. Adriana cultivated partnerships with organizations such as the Lupus Research Alliance and enhanced youth engagement through One Young World. Her efforts in diversity led to the creation of Transgender Inclusive Guidelines and leadership of the LGBTA Employee Group. Additionally, she supported Latino/Hispanic employee development and health equity initiatives.